Open AccessExpert consensus of Chinese Association for the Study of Pain on the non-opioid analgesics for chronic musculoskeletal pain
Author(s) -
Dong Huang,
Yanqing Liu,
Liangping Xia,
Xianguo Liu,
Ke Ma,
Guangzhao Liu,
Lizu Xiao,
Tao Song,
Xiaobin Yang,
Zhijian Fu,
Min Yan
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i9.2068
Subject(s) - medicine , chronic pain , musculoskeletal pain , opioid , physical therapy , association (psychology) , receptor , philosophy , epistemology
Chronic musculoskeletal pain (CMP) is a common occurrence in clinical practice and there are a variety of options for the treatment of it. However, the pharmacological therapy is still considered to be a primary treatment. The recent years have witnessed the emergence of opioid crisis, yet there are no relevant guidelines on how to treat CMP with non-opioid analgesics properly. The Chinese Medical Association for the Study of Pain convened a panel meeting to develop clinical practice consensus for the treatment of CMP with non-opioid analgesics. The purpose of this consensus is to present the application of nonsteroidal anti-inflammatory drugs, serotonin norepinephrine reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, muscle relaxants, ion channel drugs and topical drugs in CMP.